Secondary Immunodeficiency (SID) Overview
Learn About Secondary Immunodeficiency (SID)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Meghan Keaton is a Pediatrics provider in Ann Arbor, Michigan. Dr. Keaton and is rated as an Experienced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Secondary Immunodeficiency (SID) and Newborn Jaundice. Dr. Keaton is currently accepting new patients.
Regents Of The University Of Michigan
Yvonne Huang is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Ann Arbor, Michigan. Dr. Huang and is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Asthma. Dr. Huang is currently accepting new patients.
Regents Of The University Of Michigan
Matthew Dimagno is a Gastroenterologist in Ann Arbor, Michigan. Dr. Dimagno and is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Chronic Pancreatitis, Exocrine Pancreatic Insufficiency, Acute Pancreatitis, Endoscopy, and Gallbladder Removal.
Summary: The goal of this observational study is to improve the treatment of hematological patients with secondary immunodeficiency (SID) by developing a patient-reported outcome (PRO) instrument to detect clinically diagnosed infections. The study focuses on adults diagnosed with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) who are at increased risk of infections due to SID. The main questi...
Summary: The investigators propose a single center, prospective observational study in children with Lyme disease (LD), the Borrelia B-cell diagnostics (BRILLIANT) study, to assess the immune response against Borrelia burgdorferi (Bb) with the following main objectives: 1. Development of Bb-specific ASC ELISpot as a new test method for diagnosis of early LD. There is an urgent unmet clinical need for a bet...